4 ms·
No, the NIH helped with the spike protein sequence. There are plenty of other parents needed to make the actual vaccine.
by refurb 6y ago
No, the NIH helped with the spike protein sequence. There are plenty of other parents needed to make the actual vaccine.
- beckman466 6y agoIf you are knowledgeable on this, please could you write a short list of the total amount of patents the vaccine currently consists of, or link to a good source?
- refurb 6y agoThat’s not easy information to get. Startups pay a lot of money to do a “freedom to operate” study to see what patents are out there and who owns what. You can pay companies for high level info, but it’s not easy at all.
- meepmorp 6y agoYou did say > There are plenty of other parents needed to make the actual vaccine So asking for the other patents involved is a reasonable question, especially since your assertion presumably involves knowing - at least vaguely - what said patents might be.
- blywi 6y agoThis is good summary of the intellectual property situation for mRNA vaccine. The link was posted 2 weeks ago on the Twitter stream of Katalin Kariko, pioneer of mRNA vaccine technology and VP at BioNTech. https://www.ipwatchdog.com/2021/04/11/mrna-ip-competitive-landscape-one-year-covid-19-pandemic-part/id=132130/ https://www.ipwatchdog.com/2021/04/11/mrna-ip-competitive-la... https://www.ipwatchdog.com/2021/04/21/mrna-ip-competitive-landscape-translate-bio-arcturus-etherna-startups-lnp-technology-part-ii/id=132287/ https://www.ipwatchdog.com/2021/04/21/mrna-ip-competitive-la... https://www.ipwatchdog.com/2021/04/30/mrna-patent-competitive-landscape-pioneers-litigation-outlook-big-pharmas-next-moves-part-iii/id=132936/ https://www.ipwatchdog.com/2021/04/30/mrna-patent-competitiv...